ribonucleosides

Preferred Label : ribonucleosides;

MeSH definition : Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed);

MeSH annotation : deoxy or desoxy DEOXYRIBONUCLEOSIDES;

Wikipedia link : https://en.wikipedia.org/wiki/Ribonucleosides;

Is substance : O;

Détails

Origin ID

D012263;

UMLS CUI

C0035546;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Ribonucleoside (substance) [SNOMED CT concept]
- ribonucleoside [SNOMED Notion]
Record concept(s)
- ribonucleosides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1-hydroxyethyl)-5-methyl-1-beta-ribofuranosylimidazole [MeSH Supplementary Concept]
- 1 beta-D-ribofuranosylpyridin-4-one 3-carboxamide [MeSH Supplementary Concept]
- 1-(2'-O-methylribofuranosyl)imidazo(4,5-d)pyridazine-4,7(5H,6H)-dione [MeSH Supplementary Concept]
- 1-allylxanthosine [MeSH Supplementary Concept]
- 1-ribofuranosyl-3-nitropyrrole [MeSH Supplementary Concept]
- 1-ribofuranosyl-s-triazin-2(1H)-one [MeSH Supplementary Concept]
- 1-ribofuranosylimidazo(4,5-d)pyridazine-4,7(5H,6H)-dione [MeSH Supplementary Concept]
- 1-ribofuranosylpyrazole-3,4-dicarboxamide [MeSH Supplementary Concept]
- 2',3',5'-tri-O-acylribonucleoside [MeSH Supplementary Concept]
- 2'-C-cyano-2'-deoxy-1-ribopentofuranosylcytosine [MeSH Supplementary Concept]
- 2'-O-(carbomoylmethyl)ribonucleoside H-phosphonate [MeSH Supplementary Concept]
- 2,5,6-trichloro-1-(ribofuranosyl)benzimidazole [MeSH Supplementary Concept]
- 2-(2-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1-methylcarbamimidamido)acetic acid [MeSH Supplementary Concept]
- 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole [MeSH Supplementary Concept]
- 2-bromo-5,6-dichloro-1-ribopyranosyl-1H-benzimidazole [MeSH Supplementary Concept]
- 2-hydroxynicotinic acid-N-1-riboside [MeSH Supplementary Concept]
- 3'-amino-2',3'-dideoxyuridine [MeSH Supplementary Concept]
- 3,5-di-O-benzyl-1,2-isopropylidene-4C-methylribofuranose [MeSH Supplementary Concept]
- 3-(beta-D-ribofuranosyl)-2,3-dihydro-6H-1,3-oxazine-2,6-dione [MeSH Supplementary Concept]
- 3-isoxanthosine 5'-phospho-2-methylimidazole [MeSH Supplementary Concept]
- 3-ribofuranosylpyrazolo(3,4-e)(1,3)oxazine-5,7-dione [MeSH Supplementary Concept]
- 4-amino-1-ribofuranosylpyrrolo(2,3-d)pyridazin-7(6H)-one [MeSH Supplementary Concept]
- 4-amino-3-carboxamido-1-(beta-ribofuranosyl)pyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- 4-amino-5-fluoro-7H-pyrrolo(2,3-d)pyrimidine ribonucleoside [MeSH Supplementary Concept]
- 4-beta-D-ribofuranosyl-as-triazin-3(4H)-one 1-oxide [MeSH Supplementary Concept]
- 4-cyanotiazofurin [MeSH Supplementary Concept]
- 4-methylamidatetiazofurin [MeSH Supplementary Concept]
- 4-ribitylamino-2,5-diamino-6-hydroxypyrimidine [MeSH Supplementary Concept]
- 4-ribitylamino-5-amino-2,6-dihydroxypyrimidine [MeSH Supplementary Concept]
- 5'-fluoro-5'-deoxyacadesine [MeSH Supplementary Concept]
- 5-amino-1-ribofuranosyl-1,2,4-triazole-3-carboxamidine [MeSH Supplementary Concept]
- 5-amino-4-(diazoacetyl)-1-ribofuranosylimidazole [MeSH Supplementary Concept]
- 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide [MeSH Supplementary Concept]
- 5-formamido-1-beta-D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate [MeSH Supplementary Concept]
- 5-hydroxy-1-(beta-D-ribofuranosyl)-1,2,3-triazole-4-carboxamide [MeSH Supplementary Concept]
- 5-methyl-2-D-ribobenzimidazole [MeSH Supplementary Concept]
- 5-ribofuranosyl-3-(aminocarbonyl)-1-methylpyridinium [MeSH Supplementary Concept]
- 5-ribofuranosylnicotinamide [MeSH Supplementary Concept]
- 5-thiobredinin [MeSH Supplementary Concept]
- 6-(beta-ribofuranosyl)picolinamide [MeSH Supplementary Concept]
- 6-aminoallopurinol riboside [MeSH Supplementary Concept]
- 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl)quinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 6-hydroxyl-1,6-dihydropurine ribonucleoside [MeSH Supplementary Concept]
- 6-hydroxymethyl-1,6-dihydropurine ribonucleoside [MeSH Supplementary Concept]
- 6-oxo-1-(beta-D-ribofuranosyl)nicotinic acid [MeSH Supplementary Concept]
- 8-amino-6(N)-methyl-2-ribofuranosyl-1,2,3,5,6,7-hexaazaacenaphthylene [MeSH Supplementary Concept]
- 8-azanebularine [MeSH Supplementary Concept]
- 8-ribityllumazine [MeSH Supplementary Concept]
- 9-N-ribofuranosyluric acid [MeSH Supplementary Concept]
- GP 1-468 [MeSH Supplementary Concept]
- GP 1-515 [MeSH Supplementary Concept]
- L APTR [MeSH Supplementary Concept]
- N 10169 [MeSH Supplementary Concept]
- N(3),5'-cycloxanthosine [MeSH Supplementary Concept]
- N1,N6-ethanoxanthosine [MeSH Supplementary Concept]
- TI 79 [MeSH Supplementary Concept]
- acadesine [MeSH Supplementary Concept]
- allopurinol riboside [MeSH Supplementary Concept]
- alpha-ribazole [MeSH Supplementary Concept]
- carbazole ribonucleoside [MeSH Supplementary Concept]
- dapiramicin [MeSH Supplementary Concept]
- emimycin riboside [MeSH Supplementary Concept]
- furanfurin [MeSH Supplementary Concept]
- isotiazofurin [MeSH Supplementary Concept]
- isoxanthopterin-N-8-beta-D-ribofuranoside [MeSH Supplementary Concept]
- laevodosin [MeSH Supplementary Concept]
- maribavir [MeSH Supplementary Concept]
- mizoribine [MeSH Supplementary Concept]
- nebularine [MeSH Supplementary Concept]
- neopolyoxin A [MeSH Supplementary Concept]
- neopolyoxin B [MeSH Supplementary Concept]
- nicotinic acid ribonucleoside [MeSH Supplementary Concept]
- norzeatin riboside [MeSH Supplementary Concept]
- oxanosine [MeSH Supplementary Concept]
- oxypurinol 7-riboside [MeSH Supplementary Concept]
- peroxy Y nucleoside [MeSH Supplementary Concept]
- pyrazofurin [MeSH Supplementary Concept]
- pyrazomycin B [MeSH Supplementary Concept]
- ribosyl-diphthamide [MeSH Supplementary Concept]
- selenazofurin [MeSH Supplementary Concept]
- selenophenfurin [MeSH Supplementary Concept]
- succinylaminoimidazole carboxamide riboside [MeSH Supplementary Concept]
- thiophenfurin [MeSH Supplementary Concept]
- thiopurinol ribonucleoside [MeSH Supplementary Concept]
- triciribine [MeSH Supplementary Concept]
- uric acid riboside [MeSH Supplementary Concept]
- vanadyl ribonucleoside complex [MeSH Supplementary Concept]
- xanthosine [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
UMLS correspondences (same concept)
- Ribonucleoside (substance) [SNOMED CT concept]
- ribonucleoside [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients